CSI Market
Sign In | Register

Allergan plc (AGN) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access AGN Annual Cash Flow →
This page allows investors to follow Allergan plc's cash flow patterns across multiple reporting periods and assess consistency in cash generation.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2020)
3 Months 		(Dec 31 2019) (Sep 30 2019) (Jun 30 2019) (Mar 31 2019)
Operating Activities
Income379.00
Depreciation & amortization56.80
Amortization of Other Assets4.10
Minority interest0.00
Goodwill, Impairment Loss913.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase-97.90
Legal settlement0.00
Gain (Loss) on Disposition of Business0.00
Share-based Compensation51.60
Expense of compensation plans0.00
Restructuring charge0.00
Amortization Inventory Step Up-
Derivative Gain Loss On Derivative Net-
Contingent Consideration Fair Value Adjustment-
Gain Loss On Sale Of Securities And Assets-
Non Cash Impact Of Debt Extinguishment-
Deferred Income Taxes Expense Benefit-
Non Cash Tax Effect Of Gain Loss On Sale Of Business-
Contingent Consideration Adjustments Including Accretion Benefit Expense26.60
Taxes Paid In Connection With Sale Of Business-
Stock Issued-
Deferred Consideration For Acquisition-
Amortization Of Intangible Assets Including Discontinued Operations1,416.40
Conversion Of Stock Amount Converted-
Noncash Charges For Impairments And Related Items148.10
Dividends Payable Current244.50
Increase Decrease In Other Assets And Liabilities Including Receivable Or Payable With Parent-259.80
Income taxes-1,929.00
Gain (Loss) on Disposition of Stock in Subsidiary0.00
Increase (Decrease) in Accounts Receivable330.20
Increase (Decrease) in Accounts Payable and Accrued Liabilities-1,242.90
Accrued liabilities0.00
Derivative instruments0.00
Increase (Decrease) in Prepaid Expense and Other Assets-20.10
Other Working Capital-20.50
Other Noncash Income (Expense)65.20
Other net0.00
Payments for (Proceeds from) Other Operating Activities51.20
Discontinued operations0.00
Net Cash flow from Operating Activities116.50
Investing Activities
Capital Expenditures-118.00
Sale of Capital Items2.10
Short-term investments - liq.0.00
Short-term investments - acq.0.00
Proceeds from sales of other investments0.00
Proceeds From Sale Of Assets Including Intangibles And Businesses-
Proceeds From Sale Of Investments And Other Assets1,800.00
Purchases of other investments0.00
Minority interest 0.00
Proceeds from sale of investments0.00
Payments to Acquire Investments-5.00
Purchases of non-current assets0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Investment in affiliate0.00
Sale of businesses0.00
Proceeds from sale of assets0.00
Note receivable0.00
Other0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities1,679.10
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-3,031.80
Noncontrolling interest0.00
Issuances / -repurchases of Comm. Stock9.70
Exercise of stock options0.00
Issuances / -repurchases of Pref. Stock0.00
Discontinued Operations0.00
Other financing activities net0.00
Other net-2,746.80
Payment Of Contingent Consideration-
Cash Held For Sale-
Movement In Cash Held For Sale-
Payment Of Contingent Consideration And Other Financing-2.80
Payments To Settlement Of Related Party Matters-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents2,503.30
Dividends paid to minority interests0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-3,268.40
Effect of exchange rate on cash flow-31.00
Discontinued operations0.00
Free Cash Flow0.60
Total Cash Flow-1,503.80
4 historic quarters locked

Sign in to unlock the full Allergan plc cash flow history.

Sign In Create Free Account

About AGN Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.

Figures are derived from filed reports and may be restated. Historical data is subject to revision.